ERCP vs EUS: Which Procedure Do You Need?

ERCP and EUS are both endoscopic procedures for the pancreas and bile ducts, but they do very different jobs. ERCP (endoscopic retrograde cholangiopancreatography) goes inside the bile duct or pancreatic duct to treat problems — removing stones, placing stents, opening blockages. EUS (endoscopic ultrasound) uses sound waves from inside the stomach or intestine to image the pancreas, bile ducts, and surrounding tissue up close, and can collect tissue samples with a needle. Many patients need one or the other; some need both.

This explainer draws on peer-reviewed research from four gastroenterologists in the Convene directory who have published foundational work on these procedures: Robert Hawes, MD, at Orlando Health, one of the early pioneers of EUS and EUS-guided tissue sampling; Mark Topazian, M.D., at Mayo Clinic, whose work covers EUS for bile duct strictures and choledocholithiasis detection; Muhammad Hasan, MD, at AdventHealth Orlando, who ran a randomized trial comparing EUS and ERCP for biliary decompression in pancreatic cancer; and Michael Kochman, MD, at Penn Medicine, who published one of the first prospective head-to-head comparisons of EUS and ERCP for suspected pancreatic disease.

What each procedure actually does

ERCP involves a flexible scope passed through your mouth, down the esophagus, through the stomach, and into the first part of the small intestine, where the bile duct and pancreatic duct drain. The doctor threads a small tube into the duct opening and injects contrast dye, which makes the ducts visible on X-ray. The key feature of ERCP is that it can treat problems in the same session — a stone blocking the bile duct can be captured with a small basket and removed; a stricture (narrowing) can be propped open with a stent. That makes ERCP primarily a therapeutic tool.

EUS also involves a flexible scope passed through the mouth, but the tip carries a small ultrasound transducer rather than a camera lens. Once positioned in the stomach or small intestine, the scope generates real-time ultrasound images of structures the camera cannot see: the pancreas, the pancreatic duct, the bile duct, lymph nodes, and blood vessels. When something suspicious appears — a mass, an enlarged lymph node, a cyst — the doctor can pass a thin needle through the scope wall to take a tissue sample (EUS-guided fine needle aspiration, or EUS-FNA). That makes EUS primarily a diagnostic tool, though newer techniques also allow some therapeutic applications.

What the evidence shows

One of the first rigorous prospective comparisons of both procedures appeared in Endoscopy in 1993, when Michael Kochman and colleagues evaluated 69 patients with chronic abdominal pain of suspected pancreatic origin using EUS followed by ERCP [12]. Among the 30 patients ultimately diagnosed with chronic pancreatitis, EUS detected abnormalities in 24 of them — including all 19 whose ERCP showed abnormal ducts. EUS also flagged 5 patients with chronic pancreatitis whose ERCP appeared normal. That early data suggested EUS could be a sensitive first test when ERCP findings were expected to be negative or borderline.

For tissue sampling, a landmark 1999 study in Gut — involving over 600 consecutive EUS-FNA procedures at Robert Hawes' program — established the technique as safe and reliable for pancreatic and other gastrointestinal cancers [2]. EUS-FNA proved especially effective at detecting lymph node metastases that standard imaging missed. A companion study from the same year showed EUS staging of pancreatic cancer was accurate enough to guide decisions about surgical resectability [1].

For bile duct problems specifically, EUS proved valuable for strictures that ERCP could not explain. Mark Topazian and colleagues published a 2004 study in The American Journal of Gastroenterology showing that EUS-FNA of unexplained bile duct strictures — the kind that standard brushings and biopsies from ERCP often fail to diagnose — added meaningful diagnostic information and changed clinical management in many cases [7]. A 2008 follow-up study from the same team evaluated advanced molecular markers alongside imaging in patients with indeterminate strictures, helping to define when additional testing was needed beyond standard ERCP biopsies [6].

When it comes to biliary decompression in pancreatic cancer — draining a blocked bile duct caused by a tumor — ERCP has traditionally been the first-line approach, but a 2018 randomized trial published in Gastrointestinal Endoscopy showed EUS-guided stent placement worked just as well as ERCP-guided stent placement for this indication [9]. Muhammad Hasan was among the contributors to that trial, which found similar technical success rates and complication rates between the two approaches, suggesting EUS-guided biliary drainage is a legitimate option when ERCP fails or cannot be performed.

At a glance

When EUS is typically chosen first

EUS tends to come before ERCP when the clinical question is diagnostic rather than therapeutic. If your doctor is trying to figure out whether a pancreatic mass is cancer, stage it before surgery, evaluate a bile duct stricture of unknown cause, or assess a pancreatic cyst for cancer risk, EUS gives far more information than ERCP without subjecting you to ERCP's higher complication rate.

A 1998 study co-authored by Robert Hawes compared EUS head-to-head with ERCP for diagnosing and staging chronic pancreatitis [3]. EUS identified more features of chronic pancreatitis than ERCP across a range of disease severity — including early features that ERCP missed entirely. For patients with suspected chronic pancreatitis who might otherwise have needed multiple ERCP examinations to establish a diagnosis, that finding was significant.

Detecting bile duct stones (choledocholithiasis) before a planned cholecystectomy is another area where EUS and ERCP are compared routinely. A 1997 study in Radiology that included Mark Topazian found that unenhanced CT was substantially inferior to ERCP for detecting bile duct stones [14]. EUS has since shown accuracy comparable to ERCP for this indication — without ERCP's procedural risk — which is why many gastroenterologists use EUS as a screening step before committing a patient to ERCP.

When ERCP is the right choice

Once a problem in the bile duct or pancreatic duct has been identified and needs to be fixed, ERCP is generally the right tool. Removing a stone, cutting the sphincter (sphincterotomy), placing a stent to open a blockage, or obtaining tissue from inside the duct wall — these are ERCP's domain. EUS can confirm there is a stone, but it cannot remove it. EUS can show a stricture is present, but it cannot deploy a stent in the same way ERCP can.

Patients with altered anatomy from prior surgery present a particular challenge for both procedures. After a Roux-en-Y gastric bypass, reaching the bile duct opening with a standard ERCP scope is difficult or impossible. Mark Topazian and colleagues described a technique for reaching the bile duct in these patients using a single-balloon enteroscope in a 2010 study published in Endoscopy [8]. That approach extends ERCP's reach to patients who would otherwise be unable to benefit from the procedure.

Cholangioscopy: seeing inside the bile duct directly

For bile duct strictures that resist diagnosis through standard ERCP brushings or EUS-FNA, cholangioscopy is an additional option. A small camera is passed through the ERCP scope into the bile duct, allowing the doctor to see and directly biopsy suspicious areas. Robert Hawes was among the investigators in a 2011 study in Gastrointestinal Endoscopy that validated single-operator cholangioscopy in patients with bile duct disease or stones [5]. A 2015 systematic review co-authored by Muhammad Hasan found that targeted biopsies under cholangioscopic guidance substantially improved the accuracy of diagnosing indeterminate strictures compared to standard ERCP-guided brushings [10].

The evolution toward digital cholangioscopy — with higher-resolution imaging — was documented in a 2016 multicenter study that Hasan also contributed to, showing the technology was safe and useful across a range of pancreatobiliary disorders at multiple institutions [11].

Chronic pancreatitis: a case where EUS earns its keep

Diagnosing chronic pancreatitis has traditionally been difficult. ERCP shows the ducts but misses parenchymal changes in the pancreatic tissue itself. EUS sees both, which is why the field has gradually shifted toward EUS as the first-line test for suspected chronic pancreatitis.

Michael Kochman and colleagues examined the interobserver reliability of EUS for this diagnosis in a 2001 study in Gastrointestinal Endoscopy, finding that experienced endosonographers agreed on findings with reasonable consistency [13]. That agreement was not perfect — EUS interpretation still depends on the operator's experience — but it was good enough to support EUS as a reliable diagnostic tool when performed by skilled practitioners.

Questions to ask your gastroenterologist

• Is this procedure mainly for diagnosis or for treatment? That distinction usually determines whether EUS or ERCP comes first.
• If I start with EUS and you find something that needs treatment, can ERCP happen the same day or in the same admission?
• What is your volume for this procedure? Complication rates for both ERCP and EUS-FNA are significantly lower at high-volume centers.
• For a bile duct stricture: after EUS-FNA, will you still need ERCP biopsies or cholangioscopy, or do the results usually answer the question?
• If I have had gastric bypass surgery, does that change which procedure is feasible for me?

The bottom line

ERCP and EUS are complementary rather than competing procedures. EUS is the better first step when the goal is diagnosis — staging pancreatic cancer, sampling a suspicious mass or lymph node, evaluating a bile duct stricture, or detecting stones before committing to treatment. ERCP is the right tool when something in the duct system needs to be fixed. For many patients, particularly those with pancreatic cancer or complex bile duct disease, both procedures play a role. The order and combination depend on what your doctor is trying to learn or accomplish, and the decision is best made at a center where experienced endoscopists perform high volumes of both.